Institutional investors purchased a net $182.4 thousand shares of TEVA during the quarter ended March 2015, and now own 55.14% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Generic industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 7.8 Million shares of Teva Pharmaceutical
PUTNAM INVESTMENT MANAGEMENT LLC Bought 4.2 Million shares of Teva Pharmaceutical
MILLENNIUM MANAGEMENT LLC Bought 3.7 Million shares of Teva Pharmaceutical